Management of patients with HCV infection poorly tolerant to recombinant interferon alpha

Hepato-Gastroenterology

Volumn 47, Issue 31, 2000, Pages 199-203

  Cagnoni, Carlo ^a   Pancotti, D ^a   Carrara, G ^a  

^a Civile Hospital   (Italy)

Author keywords

Adverse events; Efficacy; HCV related chronic; Hepatitis; Human leukocyte interferon ; Quality of life

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON A; RECOMBINANT ALPHA INTERFERON;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE;

ADULT; ANTIVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERON-ALPHA; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUALITY OF LIFE; RETREATMENT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TREATMENT OUTCOME;

EID: 0033965828     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 1 Davis GL, Baiart LA, Schiff ER, et al: Treatment of chronic hepatitis C with recombinant Interferon alpha. A multicenter randomized, controlled trial. Hepatitis Interventional Study Group. N Engl J Med 1989; 321:1501-1506.
2. 2 Di Bisceglie AM, Martin P, Kassianides C, et al: Recombinant Interferon alpha therapy for chronic hepatitis C. A randomized double-blind, placebo-controlled trial. N Engl J Med 1989; 321:1506-1510.
3. 3 Tsubota A, Chayama K, Ikeda K, et al: Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 1994; 19:1088-1094.
4. 4 Saracco G, Rizzetto M: The long-term efficacy of interferon alpha in chronic hepatitis C patients: a critical review. J Gastroenterol Hepatol 1995; 10:668-673.
5. 5 Shindo M, Arai K, Sokawa Y, et al: Hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy. Ann Inter Med 1995; 122:586-591.
6. 6 Pagliaro L, Craxi A, Cammaa C, et al: Interferon alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. Hepatology 1994; 19:820-828.
7. 7 Reichard O, Foberg U, Fryden A, et al: High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks. Hepatology 1994; 19:280-285.
8. 8 Kasahara A, Hayashi N, Hiramatsu N, et al: Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial. Hepatology 1995; 26:291-297.
9. 9 Poynard T, Bedossa P, Chevallier M, et al: A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study group. N Engl J Med 1995; 332:1457-1462.
10. 10 Chemello L, Bonetti P, Cavalletto L, et al: Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The Triveneto Viral Hepatitis Group. Hepatology 1995; 22:700-706.
11. 11 Fried MW, Hoofnagle JH: Therapy of hepatitis C: Semin Liver Dis; 1995; 15:82-91.
12. 12 Renault PF, Hoofnagle JH, Park Y, et al: Psychiatric complications of long-term interferon alpha therapy. Arch Intern Med 1987; 147:1577-1580.
13. 13 Viscomi GC, Grimaldi M, Palazzini E, Silvestri S: Human leukocyte interferon alpha: structure, pharmacology and therapeutic applications. Medic Res Rev 1995; 15:445-478.
14. 14 Vial T, Descotes J: Drugs acting on the immune system: Interferons. In: Dukes MNG (Ed.). Meyler's Side Effects of Drugs. 13th Edition. Amsterdam: Elsevier, 1996. pp. 1090-1091.
15. 15 Colombatto P, Olivieri F, Leandro M, et al: Platelet and white blood cell counts during therapy with different types of alpha interferon in patients with chronic viral hepatitis. Ital J Gastroenterol Hepatol 1997; 29:441-447.
16. 16 Toccaceli F, Rosati S, Scuderi M, et al: Leukocyte and platelet lowering by some interferon types during viral hepatitis treatment. Hepatogastroenterology 1998; 45:1748-1752.
17. 17 Malaguarnera M, Di Fazio I, Restuccia S, et al: Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha. Neuropsychobiology 1998; 37:93-97.